Vyant Bio, Inc. discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology and machine learning.
Market Cap | 755.014 Thousand | Shares Outstanding | 818 Thousand | Avg 30-day Volume | 1.191 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.2 |
Price to Revenue | 7.4011 | Debt to Equity | 0.0285 | EBITDA | -15.271 Million |
Price to Book Value | 1.1915 | Operating Margin | -739.5422 | Enterprise Value | 7.491 Million |
Current Ratio | 1.812 | EPS Growth | -1.356 | Quick Ratio | 1.461 |
1 Yr BETA | 0.481 | 52-week High/Low | 9.85 / 0.66 | Profit Margin | -1942.4147 |
Operating Cash Flow Growth | 13.354 | Altman Z-Score | -6.7957 | Free Cash Flow to Firm | 20.406 Million |
Earnings Report | 2023-03-29 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
29,955 | 2023-01-17 | 6 | |
|
23,123 | 2023-01-17 | 5 | |
|
19,761 | 2023-01-17 | 6 | |
|
152,995 | 2023-01-17 | 5 | |
|
185,270 | 2022-04-18 | 2 | |
|
43,927 | 2022-03-30 | 1 | |
|
1,371,603 | 2022-03-30 | 1 | |
ROBERTS JOHN A CHIEF EXECUTIVE OFFICER |
|
150,000 | 2022-03-15 | 1 |
LAFRENCE ANDREW D.C. CHIEF FINANCIAL OFFICER |
|
110,000 | 2022-03-15 | 1 |
FREMEAU ROBERT THOMAS JR. CHIEF SCIENTIFIC OFFICER |
|
75,000 | 2022-03-15 | 1 |
BRANDT RALF PRESIDENT, DISCOVERY SERVICES |
|
100,000 | 2021-03-30 | 0 |
MILES MICHAEL GLENN CHIEF FINANCIAL OFFICER |
|
0 | 2020-01-02 | 0 |
|
0 | 2019-07-23 | 0 | |
|
0 | 2019-07-23 | 0 | |
|
0 | 2019-07-23 | 0 | |
|
4,781,204 | 2019-01-31 | 0 | |
FINGER WILLIAM LANSING EVP PRECISION MEDICINE |
|
0 | 2019-01-04 | 0 |
MCCARTNEY MICHAEL BRIAN CHIEF COMMERCIAL OFFICER |
|
0 | 2018-08-15 | 0 |
SHAKNOVICH RITA CHIEF MEDICAL OFFICER |
|
0 | 2018-05-10 | 0 |
|
0 | 2017-11-21 | 0 | |
|
12,540 | 2017-09-28 | 0 | |
GITELMAN IGOR CHIEF ACCOUNTING OFFICER |
|
15,000 | 2017-05-23 | 0 |
SHARMA PANNA CHIEF EXECUTIVE OFFICER |
|
0 | 2017-02-22 | 0 |
SITAR EDWARD J CHIEF FINANCIAL OFFICER |
|
14,167 | 2016-11-16 | 0 |
|
No longer subject to file | 2015-10-19 | 0 | |
EL NAGGAR JANE HOULDSWORTH VP OF RESEARCH AND DEVELOPMENT |
|
0 | 2014-12-11 | 0 |
|
5,000 | 2014-05-22 | 0 | |
|
5,000 | 2014-05-22 | 0 | |
|
2,391 | 2013-11-18 | 0 | |
|
2,500 | 2013-10-10 | 0 | |
CZEREPAK ELIZABETH CHIEF FINANCIAL OFFICER |
|
0 | 2013-04-04 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-01-19 16:30:13 -0500 | 2023-01-17 | A | 7,526 | a | 23,123 | direct | 2.2086 | 13.2515 | 13.2515 | 6 | 0.0 | 1 | ||||
2023-01-19 16:30:17 -0500 | 2023-01-17 | A | 4,368 | a | 23,895 | direct | 2.2086 | 13.2515 | 13.2515 | 6 | 0.0 | 1 | ||||
2023-01-19 16:30:27 -0500 | 2023-01-17 | A | 5,712 | a | 19,761 | direct | 2.2086 | 13.2515 | 13.2515 | 6 | 0.0 | 1 | ||||
2023-01-19 16:30:40 -0500 | 2023-01-17 | A | 4,032 | a | 152,995 | direct | 2.2086 | 13.2515 | 13.2515 | 6 | 0.0 | 1 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
VYANT BIO INC VYNT | 2023-01-27 22:15:03 UTC | -65.4455 | 69.7655 | 80000 |
VYANT BIO INC VYNT | 2023-01-27 21:45:04 UTC | -65.4455 | 69.7655 | 80000 |
VYANT BIO INC VYNT | 2023-01-27 21:15:04 UTC | -65.4455 | 69.7655 | 80000 |
VYANT BIO INC VYNT | 2023-01-27 20:45:03 UTC | -65.4455 | 69.7655 | 80000 |
VYANT BIO INC VYNT | 2023-01-27 20:15:04 UTC | -65.4455 | 69.7655 | 80000 |
VYANT BIO INC VYNT | 2023-01-27 19:45:03 UTC | -65.4455 | 69.7655 | 80000 |
VYANT BIO INC VYNT | 2023-01-27 19:15:03 UTC | -65.4455 | 69.7655 | 80000 |
VYANT BIO INC VYNT | 2023-01-27 18:45:04 UTC | -65.4455 | 69.7655 | 80000 |
VYANT BIO INC VYNT | 2023-01-27 18:15:03 UTC | -65.4455 | 69.7655 | 80000 |
VYANT BIO INC VYNT | 2023-01-27 17:45:03 UTC | -65.4455 | 69.7655 | 80000 |
VYANT BIO INC VYNT | 2023-01-27 17:15:04 UTC | -65.4455 | 69.7655 | 80000 |
VYANT BIO INC VYNT | 2023-01-27 16:45:03 UTC | -65.4455 | 69.7655 | 80000 |
VYANT BIO INC VYNT | 2023-01-27 16:15:03 UTC | -65.4455 | 69.7655 | 80000 |
VYANT BIO INC VYNT | 2023-01-27 15:45:03 UTC | -65.4455 | 69.7655 | 85000 |
VYANT BIO INC VYNT | 2023-01-27 15:15:04 UTC | -65.4455 | 69.7655 | 85000 |
VYANT BIO INC VYNT | 2023-01-27 14:45:04 UTC | -65.4455 | 69.7655 | 85000 |
VYANT BIO INC VYNT | 2023-01-27 14:15:03 UTC | -65.4455 | 69.7655 | 85000 |
VYANT BIO INC VYNT | 2023-01-27 13:45:03 UTC | -65.4455 | 69.7655 | 85000 |
VYANT BIO INC VYNT | 2023-01-27 13:15:03 UTC | -65.4455 | 69.7655 | 85000 |
VYANT BIO INC VYNT | 2023-01-27 12:45:03 UTC | -65.4455 | 69.7655 | 85000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | VYNT | -1000.0 shares, $-558.0 | 2022-09-30 | N-PORT |